microbiome — grants

Sort

24,576 grants matching “microbiome”

BCM/TCH CHOLESTATIC LIVER DISEASE CONSORTIUM

$361,048

Benjamin L. Shneider · Baylor College Of Medicine · U01 · FY2020 · DK

Characterization of the cellular and molecular bases of inborn errors of immunity

$361,036

Luigi Notarangelo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

Prospective Effects of Early Life Stress and Protective Factors on Vascular Function and Inflammation in Young Adulthood

$360,915

Sylvie Mrug · University Of Alabama At Birmingham · P01 · FY2024 · HL

A Novel Immunological-Directed Live Biotherapy Product for Treating Ulcerative Colitis

$360,624

Gary Fanger · Rise Therapeutics, Llc · R44 · FY2022 · DK

Mechanisms of Integrative and Conjugative Elements in Oral Bacteria

$360,555

Robert Colquhoun Shields · Arkansas State University · R01 · FY2024 · DE

Prevention of LUTS: Bladder Health Clinical Center, UC San Diego Site

$360,500

Emily S. Lukacz · University Of California, San Diego · U01 · FY2021 · DK

A Case-Control Study to Evaluate Broad-Spectrum Antibiotic use and High Birth Weight as Potential Risk Factors for Early-Onset Colorectal Cancer

$360,475

Chun R. Chao · Kaiser Foundation Research Institute · R01 · FY2023 · CA

Technology Core

$360,435

Granger Gideon Sutton · J. Craig Venter Institute, Inc. · U19 · FY2016 · AI

Persistent modulation of microbiota to enhance HIV vaccination

$360,407

Nichole Rose Klatt · University Of Miami School Of Medicine · R01 · FY2019 · AI

Microbiome and intestinal innate immune response in alcoholic liver disease

$360,375

Bernd G. Schnabl · University Of California, San Diego · R01 · FY2013 · AA

Study of Co-trimoxazole and Proton Pump Inhibition Using Pragmatic Design in Idiopathic Pulmonary Fibrosis - CleanUP-IPF

$360,335

Fernando J Martinez · Weill Medical Coll Of Cornell Univ · U01 · FY2018 · HL

Study of Co-trimoxazole and Proton Pump Inhibition Using Pragmatic Design in Idiopathic Pulmonary Fibrosis - CleanUP-IPF

$360,316

Fernando J Martinez · Weill Medical Coll Of Cornell Univ · U01 · FY2017 · HL

Azithromycin and the airway microbiome in asthma

$360,270

Steven R White · University Of Chicago · R34 · FY2019 · HL

Symbiosis of E. coli and the Intestinal Microbiota in a Mouse Model

$360,252

Tyrrell Conway · University Of Oklahoma · R01 · FY2013 · GM

Integration of Omic Data to Estimate Mediation or Latent Structures

$360,215

David V Conti · University Of Southern California · P01 · FY2025 · CA

Study of Co-trimoxazole and Proton Pump Inhibition Using Pragmatic Design in Idiopathic Pulmonary Fibrosis - CleanUP-IPF

$360,120

Fernando J Martinez · Weill Medical Coll Of Cornell Univ · U01 · FY2016 · HL

Developing Next-Generation Physiology approaches for human gut microbiome research

$360,000

Roland Hatzenpichler · Montana State University - Bozeman · R35 · FY2025 · GM

BCM/TCH CHOLESTATIC LIVER DISEASE CONSORTIUM

$360,000

Benjamin L. Shneider · Baylor College Of Medicine · U01 · FY2023 · DK

Developing Next-Generation Physiology approaches for human gut microbiome research

$360,000

Roland Hatzenpichler · Montana State University - Bozeman · R35 · FY2024 · GM

Improving Steps in the Development and Assessment of Live Microbiome-Based Products: Fecal Microbiota for Transplantation (FMT) and Live Biotherapeutic Products (LBPs)

$360,000

National Institute Of Allergy And Infectious Diseases · Y01 · FY2021 · AI

Improving Steps in the Development and Assessment of Live Microbiome-Based Products: Fecal Microbiota for Transplantation (FMT) and Live Biotherapeutic Products (LBPs)

$360,000

National Institute Of Allergy And Infectious Diseases · Y01 · FY2022 · AI

BCM/TCH CHOLESTATIC LIVER DISEASE CONSORTIUM

Characterization of the cellular and molecular bases of inborn errors of immunity

Prospective Effects of Early Life Stress and Protective Factors on Vascular Function and Inflammation in Young Adulthood

Gut bacterial metabolism of the side-chain of corticosteroids

NINR Intramural Research Training Programs

Early Predictors of FASD in Ukraine

Inter- and intra-epithelial regulation for intestinal barrier integrity

A Novel Immunological-Directed Live Biotherapy Product for Treating Ulcerative Colitis

Mechanisms of Integrative and Conjugative Elements in Oral Bacteria

Prevention of LUTS: Bladder Health Clinical Center, UC San Diego Site

A Case-Control Study to Evaluate Broad-Spectrum Antibiotic use and High Birth Weight as Potential Risk Factors for Early-Onset Colorectal Cancer

Technology Core

Persistent modulation of microbiota to enhance HIV vaccination

Microbiome and intestinal innate immune response in alcoholic liver disease

Study of Co-trimoxazole and Proton Pump Inhibition Using Pragmatic Design in Idiopathic Pulmonary Fibrosis - CleanUP-IPF

Study of Co-trimoxazole and Proton Pump Inhibition Using Pragmatic Design in Idiopathic Pulmonary Fibrosis - CleanUP-IPF

Azithromycin and the airway microbiome in asthma

Symbiosis of E. coli and the Intestinal Microbiota in a Mouse Model

Integration of Omic Data to Estimate Mediation or Latent Structures

Study of Co-trimoxazole and Proton Pump Inhibition Using Pragmatic Design in Idiopathic Pulmonary Fibrosis - CleanUP-IPF

Developing Next-Generation Physiology approaches for human gut microbiome research

BCM/TCH CHOLESTATIC LIVER DISEASE CONSORTIUM

Developing Next-Generation Physiology approaches for human gut microbiome research

Improving Steps in the Development and Assessment of Live Microbiome-Based Products: Fecal Microbiota for Transplantation (FMT) and Live Biotherapeutic Products (LBPs)

Improving Steps in the Development and Assessment of Live Microbiome-Based Products: Fecal Microbiota for Transplantation (FMT) and Live Biotherapeutic Products (LBPs)